API

Active Pharmaceutical Ingredients (API), popularly speaking, are the raw materials of medicines, only pharmaceutical raw materials are processed into pharmaceutical preparations , can they become medicines available for clinical use, so drugs we usually eat are the finished drugs through processing. Active Pharmaceutical Ingredients based on its sources can be divided into two major categories ,including chemical synthetic drugs and natural chemical drugs. Chemical synthetic drugs can be divided into organic synthetic drugs and inorganic synthetic drugs. Inorganic synthetic drugs are inorganic compounds ( very few is element), such as aluminum hydroxide, magnesium trisilicate which are used for the treatment of gastric and duodenal ulcers ; organic synthetic drugs are mainly composed of drugs made by basic organic chemical raw materials, through a series of organic chemical reactions (such as aspirin, chloramphenicol, caffeine, etc.). Natural chemical drugs ,based on its sources,can be divided into two categories including biochemical drugs and plant chemical drugs. Antibiotics are generally made by the microbial fermentation, which belongs to the biochemistry category. A variety of semi-synthetic antibiotics occurs in recent years,which are biosynthesis and chemical synthesis combining products.Among active Pharmaceutical Ingredients, the organic synthetic drugs varieties, yields and values have the largest proportion,which are the main pillars of the chemical and pharmaceutical industries. The quality of active Pharmaceutical Ingredients decides whether the formulation is good or bad , so its quality standards are very strict ,countries in the world have developed national pharmacopoeia standards and strict quality control methods for its widely used active Pharmaceutical ingredients.

Preparation Methods and Structural Characteristics of Hydrogenated bisphenol A (HBPA)

Hydrogenated bisphenol A (HBPA) is produced through the hydrogenation of bisphenol A. It is used as a raw material for synthesizing polyester resins.

Feb 3,2026  API

Synthetic Methods and Diazotization reaction of 4-Amino-3,5-dichlorobenzotrifluoride

4-Amino-3,5-dichlorobenzotrifluoride has been documented in the literature as a key raw material for the preparation of the insecticide fipronil.

Feb 3,2026  API

Clinical Study and Therapeutic Use of Indobufen

Indobufen is an orally active antiplatelet agent. Clinical trial data support the efficacy of indobufen in the secondary prevention of thromboembolic events.

Feb 3,2026  API

Chemical Properties and Applications of Trifluoromethanesulfonyl chloride

Trifluoromethanesulfonyl chloride serves as an efficient sulfonating agent for alcohols, it also function as a chlorinating agent for carbanions.

Feb 3,2026  API

Synthesis and Amination Reaction of 9,10-Dibromoanthracene

9,10-Dibromoanthracene can be prepared by bromination of anthracene using suitable brominating agents, for instance, liquid bromine.

Feb 2,2026  API

Synthesis and Thermal Stability of 2-Butynoic acid

As a versatile building block, 2-butynoic acid serves as an important synthetic intermediate and a foundational chemical material for pharmaceutical molecules.

Feb 2,2026  API

Biological Activity and Application of (E,E)-Farnesol

(E,E)-farnesol is a sesquiterpene acyclic alcohol synthesized by bacteria, protozoa. (E,E)-farnesol has found extensive applications in pharmaceuticals.

Jan 30,2026  API

Semisynthesis and Pharmacology of Anidulafungin

Anidulafungin is produced through a semisynthetic process from echinocandin B, exhibits a distinct metabolic profile compared to other antifungal agents.

Jan 30,2026  API

Synthetic and Analytical Methods of 2-Allyloxyethanol

Research reports have indicated 2-Allyloxyethanol can be used in the synthesis of industrial products such as fluorocarbon resins, unsaturated polyester resins.

Jan 29,2026  API

Oxaceprol: Application in Osteoarthritis

Oxaceprol, a proline-derived anti-inflammatory drug, treats osteoarthritis with comparable efficacy to tramadol and better safety than traditional NSAIDs.

Jan 29,2026  API
Prev12345678910...Next>  Go to Page